| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-48421-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43767-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43767-100ul | |||
| Azide and BSA Free | NBP3-43767-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-05838-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-05828-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06004-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-33164-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-48422-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-48423-20ul | |||
![Western Blot: Dengue Virus 1 Envelope Antibody - (US/Hawaii/1944) - Azide and BSA Free [NBP3-48421] - Lane A: Dengue Virus 1 Envelope (US/Hawaii/1944) Protein (5ng) using NBP3-48421 at 0.2ug/mL. Secondary: HRP-conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-48421_rabbit-denv-1-e-pab-us-hawaii-1944-azide-bsa-free-western-blot-2220260333114.png "Western Blot: Dengue Virus 1 Envelope Antibody - (US/Hawaii/1944) - Azide and BSA Free [NBP3-48421] - Lane A: Dengue Virus 1 Envelope (US/Hawaii/1944) Protein (5ng) using NBP3-48421 at 0.2ug/mL. Secondary: HRP-conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions.")
![Western Blot: Dengue Virus Envelope Antibody (1) - Pan Specific, (Domain III) [NBP3-43767] - NBP3-43767 in 1 ug/mL. Sample: Recombinant Protein 5 ng Lane A: Dengue virus (DENV) (type 1, strain US/Hawaii/1944) E/Envelope Protein Lane B: Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E/Envelope Protein Lane C: Dengue virus (DENV) (type 3, strain Philippines/H87/1956) E / Envelope Protein Lane D: Dengue virus (DENV) (type 4, strain Philippines/H241/1956) E / Envelope Protein Secondary Goat Anti-Rabit IgG (H+L) [HRP] at 1/10000 dilution Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-43767_rabbit-dengue-virus-envelope-mab-1-pan-domain-iii-235202514371317.png "Western Blot: Dengue Virus Envelope Antibody (1) - Pan Specific, (Domain III) [NBP3-43767] - NBP3-43767 in 1 ug/mL. Sample: Recombinant Protein 5 ng Lane A: Dengue virus (DENV) (type 1, strain US/Hawaii/1944) E/Envelope Protein Lane B: Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E/Envelope Protein Lane C: Dengue virus (DENV) (type 3, strain Philippines/H87/1956) E / Envelope Protein Lane D: Dengue virus (DENV) (type 4, strain Philippines/H241/1956) E / Envelope Protein Secondary Goat Anti-Rabit IgG (H+L) [HRP] at 1/10000 dilution Developed using the ECL technique. Performed under reducing conditions.")
![Western Blot: Dengue Virus 2 Envelope Antibody (201) - (Domain III) [NBP3-05838] - NBP3-05838 at 1:2000 dilution Sample:Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E / Envelope Protein (Domain III) Recombinant Protein Lane A: 30ng Secondary Rabbit Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-05838_mouse-monoclonal-dengue-virus-2-envelope-antibody-201-domain-iii-235202511354138.png "Western Blot: Dengue Virus 2 Envelope Antibody (201) - (Domain III) [NBP3-05838] - NBP3-05838 at 1:2000 dilution Sample:Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E / Envelope Protein (Domain III) Recombinant Protein Lane A: 30ng Secondary Rabbit Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution Performed under reducing conditions.")
![Western Blot: Dengue Virus 2 Envelope Antibody (144) - (Domain III) [NBP3-05828] - NBP3-05828 at 1:2000 dilution Sample:Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E / Envelope Protein (Domain III) Recombinant Protein Lane A: 30ng Secondary Rabbit Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-05828_mouse-monoclonal-dengue-virus-2-envelope-antibody-144-domain-iii-2352025112931.png "Western Blot: Dengue Virus 2 Envelope Antibody (144) - (Domain III) [NBP3-05828] - NBP3-05828 at 1:2000 dilution Sample:Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E / Envelope Protein (Domain III) Recombinant Protein Lane A: 30ng Secondary Rabbit Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution Performed under reducing conditions.")
![Western Blot: Dengue Virus 2 Envelope Antibody [NBP3-06004] - Anti-Dengue virus 2 envelope antibody at 1:2000 dilution Sample: Dengue virus (DENV)(type 2,strain New Guinea CUO-218 hybrid) E Envelope Protein (ECD,His Tag)Lane A: 5ng Secondary:Goat Anti-Rabbit IgG (H+L) HRP at 110000 dilution.Developed using the ECL technique.Performed under reducing conditions.](http://images.novusbio.com/fullsize/Dengue-Virus-2-Envelope-Antibody-Western-Blot-NBP3-06004-img0001.jpg "Western Blot: Dengue Virus 2 Envelope Antibody [NBP3-06004] - Anti-Dengue virus 2 envelope antibody at 1:2000 dilution Sample: Dengue virus (DENV)(type 2,strain New Guinea CUO-218 hybrid) E Envelope Protein (ECD,His Tag)Lane A: 5ng Secondary:Goat Anti-Rabbit IgG (H+L) HRP at 110000 dilution.Developed using the ECL technique.Performed under reducing conditions.")
![Western Blot: Dengue Virus 2 Envelope Antibody - (Domain III), (New Guinea C/PUO-218 hybrid) [NBP3-33164] - NBP3-33164 at 1:5000 dilution. Lane A: Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E / Envelope Protein (Domain III) Recombinant Protein (5 ng) Secondary Goat Anti-Rabbit IgG (H+L) [HRP] at 1/10000 dilution Developed using the ECL technique. Performed under reducing conditions.](http://images.novusbio.com/fullsize/nbp3-33164_rabbit-dnv2-env-pab-domain-3-hybrid-azide-bsa-free-235202511545689.png "Western Blot: Dengue Virus 2 Envelope Antibody - (Domain III), (New Guinea C/PUO-218 hybrid) [NBP3-33164] - NBP3-33164 at 1:5000 dilution. Lane A: Dengue virus (DENV) (type 2, strain New Guinea C/PUO-218 hybrid) E / Envelope Protein (Domain III) Recombinant Protein (5 ng) Secondary Goat Anti-Rabbit IgG (H+L) [HRP] at 1/10000 dilution Developed using the ECL technique. Performed under reducing conditions.")